Article metrics

Download PDFPDF

Correction: Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles

 

Online download statistics by month:

Online download statistics by month: April 2018 to December 2019

AbstractFullPdf
Apr 201819819928
May 201812612824
Jun 2018616410
Jul 201833336
Aug 2018424212
Sep 201838386
Oct 201828286
Nov 201825265
Dec 201818183
Jan 201921213
Feb 201928273
Mar 201918189
Apr 201921218
May 2019161612
Jun 2019202011
Jul 2019242413
Aug 201916168
Sep 2019997
Oct 201911116
Nov 201913147
Dec 201912126
Total778785193